Medtas Pharmaceuticals Private Limited

Medtas Pharmaceuticals Private Limited - trading in Sant Kabir Nagar, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U74120UP2014PTC066348 Incorporated 30 September 2014 ROC Kanpur HQ Sant Kabir Nagar, Uttar Pradesh, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2020
₹69.24 Lakh
▼ 31% YoY
Net profit · FY 2020
₹56,288
Net margin 0.8%
EBITDA · FY 2020
₹6.23 Lakh
EBITDA margin 9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Medtas Pharmaceuticals Private Limited

Data last updated:

Medtas Pharmaceuticals Private Limited is a private limited company based in Sant Kabir Nagar, Uttar Pradesh, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 30 September 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74120UP2014PTC066348. Its GSTIN is 09AAJCM5296Q1ZE (Uttar Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ravi Kumar Pushpjivi and Veerendra Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Village And Post – Shanichara Bazar Tehsil – Dhanghata, Sant Kabir Nagar, Uttar Pradesh, India – 272162.

As per the financials filed for FY 2020, the company reported a revenue of ₹69.24 Lakh, a decline of 31% compared to the previous year. For the same year it recorded a net profit of ₹56,288 (net margin 0.8%) and EBITDA of ₹6.23 Lakh (EBITDA margin 9%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74120UP2014PTC066348
Registration Number 066348
Incorporation Date 30 September 2014
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Medtas Pharmaceuticals Private Limited's registered office is in Sant Kabir Nagar, Uttar Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Village And Post – Shanichara Bazar Tehsil – Dhanghata, Sant Kabir Nagar, Uttar Pradesh, India – 272162
  • Industry
    Trading, Wholesale, Other Wholesale, Retailers, Retail Trading

To see the full contact details of Medtas Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Medtas Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Medtas Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Medtas Pharmaceuticals Private Limited, buy the company report.

Financials of Medtas Pharmaceuticals Private Limited

FY 2025 filings available

Medtas Pharmaceuticals Private Limited reported revenue of ₹69.24 Lakh (down 31% YoY) for FY 2020.

Revenue · FY 2020
₹69.24 Lakh ▼ 31%
Net profit · FY 2020
₹56,288 margin 0.8%
EBITDA · FY 2020
₹6.23 Lakh margin 9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 31%
3 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▼ 57%
3 years · compounded
▲ 97%

Revenue fell 31% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 57% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations₹69.24 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6.23 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹56,288
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin9%
Net Profit Margin0.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medtas Pharmaceuticals Private Limited, buy the company report.

Board of directors of Medtas Pharmaceuticals Private Limited

Medtas Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Ravi Kumar PushpjiviDirector30 Sep 201412 Years 1 MonthsCurrent
Veerendra KumarDirector30 Sep 201412 Years 1 MonthsCurrent

Auditor

Medtas Pharmaceuticals Private Limited is audited by R.P.GUPTA & CO. for the financial year 2017.

Auditor firmFinancial yearFirm registration number
R.P.GUPTA & CO.FY 2017408016

Shareholding

The shareholding of Medtas Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Medtas Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medtas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Medtas Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAJCM5296Q1ZEUttar PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Medtas Pharmaceuticals Private Limited, buy the company report.

Recent activity

Medtas Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Ravi Kumar Pushpjivi was appointed as Director on 30 Sep 2014.

AGM
Medtas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medtas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Ravi Kumar Pushpjivi was appointed as Director.
Appointed
Veerendra Kumar was appointed as Director.
Incorporation
30 Sep 2014
Medtas Pharmaceuticals Private Limited was registered on 30 Sep 2014 with Roc Kanpur & aged 12 years 1 month as per MCA records.

Frequently asked questions

Medtas Pharmaceuticals is an active private limited company based in Sant Kabir Nagar, Uttar Pradesh, India. The company works in wholesale, within the trading industry. It was incorporated on 30 September 2014 (12+ years old) and is registered under CIN U74120UP2014PTC066348.

Medtas Pharmaceuticals has 2 current directors:

The latest financial statements of Medtas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Medtas Pharmaceuticals is 09AAJCM5296Q1ZE, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Medtas Pharmaceuticals is U74120UP2014PTC066348. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medtas Pharmaceuticals was incorporated on 30 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kanpur.

Ravi Kumar Pushpjivi was appointed as Director on 30 Sep 2014. Veerendra Kumar was appointed as Director on 30 Sep 2014.

The registered office of Medtas Pharmaceuticals is at Village And Post – Shanichara Bazar Tehsil – Dhanghata, Sant Kabir Nagar, Uttar Pradesh, India – 272162.

Medtas Pharmaceuticals operates in the trading industry, in the wholesale segment.

The compliance status of Medtas Pharmaceuticals is compliant as of 31 July 2026. The company is actively filing with the Registrar of Companies.